Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

related to degree

  • Tichenor, Mark, Ph.D. in Chemistry, Scripps Research 2002 - 2007
  • Kastrinsky, David, Ph.D. in Synthetic Organic Chemistry, Scripps Research 2000 - 2005

authors

  • Tichenor, Mark
  • Kastrinsky, David
  • Boger, Dale

publication date

  • July 2004

journal

  • Journal of the American Chemical Society  Journal

abstract

  • The total synthesis of the reported structure 2 for yatakemycin, an exceptionally potent, naturally occurring antitumor agent disclosed in 2003, and its lack of correlation with the natural product are detailed. On the basis of spectroscopic distinctions between 2 and yatakemycin, the natural product structure was reformulated as 3, now bearing a thiomethyl ester versus thioacetate in the left-hand subunit. Total synthesis of 3 provided a compound nearly identical to but still subtly distinct from the natural product. A second reformulation of the yatakemycin structure as 1, incorporating the alternatively substituted right-hand subunit as well as the initial thiomethyl ester reformulation, was confirmed by total synthesis of both (+)- and ent-(-)-1 in studies that also unambiguously established the absolute configuration of the natural product.

subject areas

  • Indoles
  • Pyrroles
  • Stereoisomerism
  • Streptomyces
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0002-7863

Digital Object Identifier (DOI)

  • 10.1021/ja0472735

PubMed ID

  • 15237994
scroll to property group menus

Additional Document Info

start page

  • 8396

end page

  • 8398

volume

  • 126

issue

  • 27

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support